NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

3A and 3C. We’ve talked about 3C at length on this board, so no reason to go back explaining that. Safe to say, there is a reason Dr. Ashkan is very excited. There is a reason why Jerry Jasinowsi stated the latter (blinded) data look particularly good. There is a reason Dr. Liau does not want anyone subjected to a placebo control arm plus Temodar. There is a reason Dr. Stupp readily admits Temodar does not work in unmethylated. There is a reason Merck is winding down it’s Temodar assistance program. There is a reason Linda Powers states this is likely the last concurrent (now hybrid) control trial possible for DCVax-l as the experimental arm. There is a reason the new endpoints will help transition future trial indications away from placebo controlled trials. There is a reason DCVax-l is the control in the combination trial. There is a reason LL can tell if a patient’s immune system needs a booster. There are reasons for everything. That said, where’s the Journal???